Janiczek Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Janiczek Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15	Closed	-$8K	–	917
2022 Q2	$8K	Sell	15 -100	-87%	-$52.1K	﹤0.01%	596
2022 Q1	$65K	Sell	115 -1	-0.9%	-$603	0.02%	265
2021 Q4	$88K	Buy	116 +33	+40%	+$24.7K	0.03%	206
2021 Q3	$62K	Buy	83 +12	+17%	+$8.99K	0.02%	248
2021 Q2	$46K	Buy	71 +6	+9%	+$3.65K	0.02%	269
2021 Q1	$37K	Buy	65 +1	+2%	+$592	0.01%	284
2020 Q4	$37K	Buy	64 +58	+967%	+$33K	0.02%	246
2020 Q3	$3K	Hold	6	–	–	﹤0.01%	425
2020 Q2	$3K	Buy	+6	New	+$2.65K	﹤0.01%	229

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Janiczek Wealth Management's BIO Position: Q3 2022 in Review

Janiczek Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 15 shares — an estimated $8K sold.

Janiczek Wealth Management first reported a position in BIO in Q2 2020 and held it in 9 quarters. The position peaked at $88K in Q4 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

Janiczek Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
Janiczek Wealth Management sold 15 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $8K.
Janiczek Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 9 quarters.
Janiczek Wealth Management's Bio-Rad Laboratories Class A position peaked at $88K in Q4 2021.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Janiczek Wealth Management's 13F filing for Q3 2022, filed 17 Oct 2022.